The Invitational was created many moons ago to showcase the "newcomers" in the micro-cap world and highlight those companies that are flying under the radar of investors. Since its inception in 2010, the event has been the launchpad for many of the successful names that you find small-cap today. This event is the perfect opportunity for investors to get a glimpse of the "future" and get a feel for what the next generation of up-and-comers will look like.
June 07, 2022
Cryptocurrency adoption is taking off around the world. The user rate is growing at over 100% each year, with 300 million current crypto users worldwide and a projected 4 billion users by 2030. There are over 18,000 businesses worldwide accepting crypto including Microsoft, Sotheby's, PayPal and Visa. What does this mean for the future? Pull up a chair and join us for the Sequire Blockchain and Crypto Conference to find out. This event will feature presentations, panels, and keynotes from some of the industry's top companies and experts. Register today!
June 23, 2022
In a world where more and more of us are doing business exclusively online, it's no surprise that the fintech industry has taken off. Valued at USD 7,301.78 billion in 2020, the financial tech industry is expected to reach a value of 31,503.54 billion by 2026. Interested in learning more? Then join us on Thursday, May 19th for the Sequire Fintech Conference. During this free event, we'll discuss everything going on in the fintech world through panels, keynotes and company presentations.
May 19, 2022
Don't trip, but the Sequire Cannabis & Psychedelic Conference is back on Wednesday, April 20th, 2022. Hear from over 30 top public companies in the cannabis, CBD, and psychedelic space. We will also be hosting industry experts and special guests for keynotes and panels.
April 20, 2022
This one-day event will be hosted by The B. Riley Securities Equity Research team and feature one-on-one discussions, fireside chats, and presentations hitting on key topics across the supply chain of drug development with international life sciences services providers enabling innovative drug creation. It provides an excellent opportunity for investors to learn state-of-the-art developments and competitive landscape of key enabling technologies that form the backbone of biopharma and academia R&D activities, ranging from sample/workflow management, material & equipment transfer/storage, and AI/ML techniques aimed at improving proficiency and efficiency of large and small biopharma drug sponsors.
April 07, 2022
The B. Riley Securities research team is delighted to host a two-day R&D summit from Tuesday, April 5 through Wednesday, April 6, during which Fortress Biotech’s innovative business model will be on full display with a focus on strategically acquiring, developing, commercializing, and monetizing de-risked therapeutic products and product candidates. The summit will feature panel presentations from the FBIO management team as well as both public and private partner and subsidiary companies including, Cyprium Therapeutics and Caelum Biosciences, showcasing FBIO’s business development capabilities, and Journey Medical (DERM), Checkpoint Therapeutics (CKPT), and Mustang Bio (MBIO), each the latter two of which have key upcoming data and regulatory catalysts.
April 05, 2022